Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
245 EUR | -0.08% | -2.62% | +15.68% |
Sales 2024 * | 60.04B 65.92B 61.48B 5,250B | Sales 2025 * | 63.83B 70.08B 65.37B 5,582B | Capitalization | 178B 196B 183B 15,607B |
---|---|---|---|---|---|
Net income 2024 * | 13.31B 14.62B 13.63B 1,164B | Net income 2025 * | 14.75B 16.2B 15.11B 1,290B | EV / Sales 2024 * | 3.21 x |
Net Debt 2024 * | 14.24B 15.63B 14.58B 1,245B | Net Debt 2025 * | 8.17B 8.97B 8.36B 714B | EV / Sales 2025 * | 2.92 x |
P/E ratio 2024 * |
13
x | P/E ratio 2025 * |
11.8
x | Employees | - |
Yield 2024 * |
4.4% | Yield 2025 * |
4.55% | Free-Float | 88.91% |
Latest transcript on Roche Holding AG
1 day | -0.08% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 31/12/02 | |
Severin Schwan
CHM | Chairman | 57 | 31/12/07 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 31/03/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 02/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 31/12/95 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-4.04% | 145B | |
-10.94% | 144B |
- Stock Market
- Equities
- ROG Stock
- RHO Stock